Major Novartis shareholder calls for board shake-up after trial setbacks on September 12, 2026 acquisition activism Artisan Partners Avidity board shake-up clinical-trial setbacks corporate governance David Samra Giovanni Caforio M&A strategy Novartis shareholder +
Major Novartis shareholder calls for board shake-up after trial setbacks on September 11, 2026 acquisitions Artisan Partners Avidity board shake-up corporate governance David Samra drug-trial Giovanni Caforio MorphoSys Novartis setbacks +
Mochida Pharmaceutical: Notice Concerning Changes in Directors on May 15, 2026 Board of Directors Changing corporate governance directors executive appointments Japan Leadership Mochida Pharmaceutical Tokyo Stock Exchange +